Continuous glucose monitoring system (Photo 212233758 © Dragoljub Bankovic | Dreamstime.com)

By Kevin Rothwell

60,000 eligible over three years

B.C. Pharmacare coverage extended to help diabetics

Jun 11, 2021 | 11:26 AM

VICTORIA – Good news for the thousands of British Columbians living with diabetes, the province has announced it will now have the Dexcom G6, a continuous glucose monitor (CGM) that provides regular updates on blood glucose levels throughout the day, covered through BC PharmaCare.

“Thousands of British Columbians will benefit from coverage of continuous glucose monitors, which will allow patients to stay on top of their glucose levels with an easy, convenient system and will help patients and their health-care providers make better treatment decisions,” Adrian Dix, Minister of Health said. “We are grateful for the record number of British Columbians who provided input during our review of continuous glucose monitors.”

CGMs let people living with diabetes automatically tracking glucose levels in real time. CGMs send regular readings of glucose levels to a device, such as a compatible smartphone or a reader, including push alerts when the patient’s blood glucose levels are outside a defined range. This enables patients or their caregivers to take action sooner, and helps protect people by empowering patients, caregivers and clinicians to identify glucose trends and adjust medications, activity and food intake.

With CGMs, a small sensor is attached to the skin on a patient’s abdomen or upper buttock. The Dexcom G6 sensor lasts 10 days before it must be replaced, and the Dexcom G6 transmitter can be used for 90 days.

These devices are expected to benefit almost 20,000 British Columbians each year in the first three years. At list price, it would have cost approximately $100 million over three years to implement coverage for the Dexcom G6 CGM. The province has successfully negotiated a discount.

One Man's Opinion

COLLINS: Are the B.C. Conservatives digging their own graves?

7h ago

Sound Off

SOUND OFF: Culturally appropriate food goes beyond the ingredients on a plate

Dec 14, 2024

Two and Out

PETERS: Whether building up or tearing down, Kamloops is what you make it

Dec 13, 2024

The Dexcom G6 CGM will be a limited-coverage benefit, meaning coverage is available to people with diabetes who meet the special authority criteria for CGMs. For patients who receive special authority approval, coverage will be provided to people enrolled in Fair PharmaCare and to those with PharmaCare coverage through Plan C (income assistance), Plan F (children in the At Home program) or Plan W (First Nations health benefits).

On average, over 29,000 people are diagnosed with diabetes every year in British Columbia. Diabetes affects the body’s ability to regulate blood glucose levels. The complications of poorly controlled diabetes range from acute (e.g., fatigue, ketoacidosis and seizures) to chronic (e.g., nerve and organ damage).

In Canada, diabetes is the sixth leading cause of death, and the leading cause of blindness, end-stage kidney disease and non-traumatic amputation.

In January 2019, B.C. made a $105-million investment over three years to reduce and/or eliminate Fair PharmaCare deductibles and co-payments for lower-income British Columbians.